Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) ...
Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) Efficacy and safety results from an additional ARANOTE trial subgroup analysis …